Clinical Trial

taVNS or TMS or Both for Depression

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the research is to test out a combined treatment for depression where the investigators stimulate a nerve in the ear while at the same time stimulate the brain with magnets. These treatments are called transcutaneous (through the skin) auricular (ear) vagus nerve stimulation (taVNS) and transcranial (through the skull) magnetic stimulation (TMS). For participants who already have a cervical VNS device, the investigators will not change their treatment and will use this in place of the taVNS. The investigators think this combined method might treat depressive symptoms better than either alone. This study is in person at the Institute of Psychiatry in downtown Charleston on the MUSC campus. First, participants will have a screening session and then will have 6 treatment days total where participants will receive either VNS treatment alone, TMS treatment alone, or both at the same time. The treatment that participants start with will be randomized, and they will have 2 treatment days of each combination.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-01 -> 2027-06-01 2026-08-13
minor Completion pushed: 2026-07-01 -> 2027-07-01 2026-08-13
Trial Details
NCT Number NCT05725239
Lead Sponsor Medical University of South Carolina
Conditions Depression
Enrollment 24 participants
Start Date 2023-03-14
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-12